BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
13,790
+100 (0.73%)
At close: Mar 12, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 119.91 billion as of March 13, 2026. Its market cap has decreased by -2.20% in one year.
Market Cap
119.91B
Enterprise Value
69.08B
Revenue
18.82B
Ranking
n/a
PE Ratio
16.60
Stock Price
13,790.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 119.91B, a decrease of -37.88%. That is a compound annual growth rate of -11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 119.91B | -12.72% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 144.81B |
| ViGenCell | 124.23B |
| CORESTEMCHEMON | 121.77B |
| NovMetaPharma | 114.03B |
| Quratis | 100.52B |
| Cell Biotech | 99.99B |
| TegoScience | 95.76B |
| CTCBIO | 94.92B |